These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 20971189)
1. Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy. Ghimire M; Hodges LA; Band J; Lindsay B; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN Eur J Pharm Biopharm; 2011 Jan; 77(1):148-57. PubMed ID: 20971189 [TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets. Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400 [TBL] [Abstract][Full Text] [Related]
3. A pharmacoscintigraphic study of three time-delayed capsule formulations in healthy male volunteers. McConville JT; Hodges LA; Jones T; Band JP; O'Mahony B; Lindsay B; Ross AC; Florence AJ; Stanley AJ; Humphrey MJ; Wilson CG; Stevens HN J Pharm Sci; 2009 Nov; 98(11):4251-63. PubMed ID: 19387976 [TBL] [Abstract][Full Text] [Related]
4. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118 [TBL] [Abstract][Full Text] [Related]
5. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates. Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325 [TBL] [Abstract][Full Text] [Related]
6. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets. Lin SY; Lin KH; Li MJ J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050 [TBL] [Abstract][Full Text] [Related]
7. Gamma scintigraphy in the analysis of ketoprofen behaviour from matrix tablets. Vueba ML; Rodrigues A; Lourenço P; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Int J Pharm; 2013 May; 448(1):298-304. PubMed ID: 23541984 [TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate. Pradhan R; Kim YI; Chang SW; Kim JO Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032 [TBL] [Abstract][Full Text] [Related]
9. Scintigraphic evaluation of the in vivo performance of dry-coated delayed-release tablets in humans. Kambayashi A; Sako K; Kondo H Eur J Pharm Biopharm; 2020 Jul; 152():116-122. PubMed ID: 32380166 [TBL] [Abstract][Full Text] [Related]
10. Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations. Hamza Yel-S; Aburahma MH Drug Dev Ind Pharm; 2010 Mar; 36(3):337-49. PubMed ID: 19722915 [TBL] [Abstract][Full Text] [Related]
11. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. Ghimire M; McInnes FJ; Watson DG; Mullen AB; Stevens HN Eur J Pharm Biopharm; 2007 Sep; 67(2):515-23. PubMed ID: 17498934 [TBL] [Abstract][Full Text] [Related]
12. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867 [TBL] [Abstract][Full Text] [Related]
13. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications. Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316 [TBL] [Abstract][Full Text] [Related]
14. Continuous twin screw melt granulation of glyceryl behenate: Development of controlled release tramadol hydrochloride tablets for improved safety. Keen JM; Foley CJ; Hughey JR; Bennett RC; Jannin V; Rosiaux Y; Marchaud D; McGinity JW Int J Pharm; 2015 Jun; 487(1-2):72-80. PubMed ID: 25839417 [TBL] [Abstract][Full Text] [Related]
15. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system. Kumar RV; Sinha VR Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913 [TBL] [Abstract][Full Text] [Related]
16. Compression-coated tablets of glipizide using hydroxypropylcellulose for zero-order release: in vitro and in vivo evaluation. Huang H; Wu Z; Qi X; Zhang H; Chen Q; Xing J; Chen H; Rui Y Int J Pharm; 2013 Mar; 446(1-2):211-8. PubMed ID: 23370433 [TBL] [Abstract][Full Text] [Related]